Enlivex Therapeutics Ltd.Enlivex Therapeutics Ltd.Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd.

No trades
See on Supercharts
Market capitalization
‪24.17 M‬USD
−1.56USD
‪−29.07 M‬USD
‪14.97 M‬
Beta (1Y)
1.78

About Enlivex Therapeutics Ltd.

CEO
Oren Hershkovitz
Headquarters
Ness Ziona
Founded
2012
ISIN
IL0011319527
FIGI
BBG005ZL1Z86
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. The company was founded by Dror Mevorach on January 22, 2012 and is headquartered in Ness Ziona, Israel.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ENLV is 1.36 USD — it has increased by 4.59% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Enlivex Therapeutics Ltd. stocks are traded under the ticker ENLV.
Enlivex Therapeutics Ltd. is going to release the next earnings report on May 24, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for Enlivex Therapeutics Ltd. has a max estimate of 7.00 USD and a min estimate of 7.00 USD.
ENLV earnings for the last quarter are −0.32 USD whereas the estimation was −0.32 USD which accounts for 0% surprise. Estimated earnings for the next quarter are −0.28 USD. See more details about Enlivex Therapeutics Ltd. earnings.
Yes, you can track Enlivex Therapeutics Ltd. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ENLV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Enlivex Therapeutics Ltd. stock right from TradingView charts — choose your broker and connect to your account.
ENLV reached its all-time high on Jul 31, 2014 with the price of 264.00 USD, and its all-time low was 1.20 USD and was reached on Dec 13, 2023.
See other stocks reaching their highest and lowest prices.